ALK GENE MUTATION
Clinical trials for ALK GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ALK GENE MUTATION trials appear
Sign up with your email to follow new studies for ALK GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study seeks best dose of targeted drug for ALK lung cancer
Disease control Recruiting nowThis study is for people with advanced ALK-positive non-small cell lung cancer. It tests three different doses of the drug alectinib to see how the body processes each dose and which dose works best. The goal is to find the safest and most effective dose to control the cancer.
Matched conditions: ALK GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Lung cancer rebiopsy study seeks to outsmart drug resistance
Knowledge-focused Recruiting nowThis study looks at why some lung cancer cells survive targeted treatment. Researchers will take small tissue samples (biopsies) before and two weeks after starting therapy to spot early signs of resistance. The goal is to find ways to block these survival pathways and make treat…
Matched conditions: ALK GENE MUTATION
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC